Search Results - "Rush, AJ"

The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation by Trivedi, M H, Rush, A J, Ibrahim, H M, Carmody, T J, Biggs, M M, Suppes, T, Crismon, M L, Shores-Wilson, K, Toprac, M G, Dennehy, E B, Witte, B, Kashner, T M

“…The present study provides additional data on the psychometric properties of the 30-item Inventory of Depressive Symptomatology (IDS) and of the recently…”
Get more information

The impact of treatment-resistant depression on health care utilization and costs by Crown, William H, Finkelstein, Stan, Berndt, Ernst R, Ling, Davina, Poret, Amy W, Rush, A John, Russell, James M

“…Approximately 50% of patients diagnosed with major depressive disorder will experience a recurrent or chronic course of illness for which long-term treatment…”
Get full text

Maintenance Phase Efficacy of Sertraline for Chronic Depression: A Randomized Controlled Trial by Keller, Martin B, Kocsis, James H, Thase, Michael E, Gelenberg, Alan J, Rush, A. John, Koran, Lorrin, Schatzberg, Alan, Russell, James, Hirschfeld, Robert, Klein, Daniel, McCullough, James P, Fawcett, Jan A, Kornstein, Susan, LaVange, Lisa, Harrison, Wilma, for the Sertraline Chronic Depression Study Group

“…CONTEXT.— The chronic form of major depression is associated with a high rate of prevalence and disability, but no controlled research has examined the impact…”
Get full text

EPH62 How Effective Is Antidepressant Medication (ADM) Polypharmacy in Difficult to Treat Depression (DTD)? a Neuroblu Electronic Health Record (EHR) Report by Guruswamy, G, Valko, M, Rush, AJ, Kollins, SH

Get full text

Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STARD: Implications for Clinical Practice by Trivedi, Madhukar H., Rush, A. John, Wisniewski, Stephen R., Nierenberg, Andrew A., Warden, Diane, Ritz, Louise, Norquist, Grayson, Howland, Robert H., Lebowitz, Barry, McGrath, Patrick J., Shores-Wilson, Kathy, Biggs, Melanie M., Balasubramani, G. K., Fava, Maurizio

“…OBJECTIVE: Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat depression, but the rates, timing, and baseline predictors of remission in…”
Get full text

The Epidemiology of Major Depressive Disorder: Results From the National Comorbidity Survey Replication (NCS-R) by Kessler, Ronald C, Berglund, Patricia, Demler, Olga, Jin, Robert, Koretz, Doreen, Merikangas, Kathleen R, Rush, A. John, Walters, Ellen E, Wang, Philip S

“…CONTEXT Uncertainties exist about prevalence and correlates of major depressive disorder (MDD). OBJECTIVE To present nationally representative data on…”
Get full text

Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression by Rush, A. John, Trivedi, Madhukar H, Wisniewski, Stephen R, Stewart, Jonathan W, Nierenberg, Andrew A, Thase, Michael E, Ritz, Louise, Biggs, Melanie M, Warden, Diane, Luther, James F, Shores-Wilson, Kathy, Niederehe, George, Fava, Maurizio

“…Adult outpatients with a nonpsychotic major depressive disorder received sustained-release bupropion, sertraline, or extended-release venlafaxine after a lack…”
Get full text

Medication Augmentation after the Failure of SSRIs for Depression by Trivedi, Madhukar H, Fava, Maurizio, Wisniewski, Stephen R, Thase, Michael E, Quitkin, Frederick, Warden, Diane, Ritz, Louise, Nierenberg, Andrew A, Lebowitz, Barry D, Biggs, Melanie M, Luther, James F, Shores-Wilson, Kathy, Rush, A. John

“…Although clinicians frequently add a second medication to an ineffective antidepressant, randomized trials comparing augmentation medications are lacking. In…”
Get full text

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression by Rush, A.John, Trivedi, Madhukar H, Ibrahim, Hicham M, Carmody, Thomas J, Arnow, Bruce, Klein, Daniel N, Markowitz, John C, Ninan, Philip T, Kornstein, Susan, Manber, Rachel, Thase, Michael E, Kocsis, James H, Keller, Martin B

“…The 16-item Quick Inventory of Depressive Symptomatology (QIDS), a new measure of depressive symptom severity derived from the 30-item Inventory of Depressive…”
Get full text

Sertraline as a first‐line treatment for cholestatic pruritus by Mayo, Marlyn J., Handem, Iorna, Saldana, Sandra, Jacobe, Heidi, Getachew, Yonas, Rush, A. John

“…Pruritus is frequently the most debilitating symptom of cholestatic liver diseases. Moreover, existing therapies are often ineffective. Recent small,…”
Get full text

Variation in the Gene Encoding the Serotonin 2A Receptor Is Associated with Outcome of Antidepressant Treatment by McMahon, Francis J., Buervenich, Silvia, Charney, Dennis, Lipsky, Robert, Rush, A. John, Wilson, Alexander F., Sorant, Alexa J.M., Papanicolaou, George J., Laje, Gonzalo, Fava, Maurizio, Trivedi, Madhukar H., Wisniewski, Stephen R., Manji, Husseini

“…Depressive disorders account for a large and increasing global burden of disease. Although the condition of many patients improves with medication, only a…”
Get full text

Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice by Fava, Maurizio, Rush, A John

“…Most patients with major depressive disorder (MDD) do not reach symptom remission. These patients with residual symptoms have worse function and worse…”
Get more information

The FKBP5 -Gene in Depression and Treatment Response—an Association Study in the Sequenced Treatment Alternatives to Relieve Depression (STARD) Cohort by Lekman, Magnus, Laje, Gonzalo, Charney, Dennis, Rush, A. John, Wilson, Alexander F, Sorant, Alexa J.M, Lipsky, Robert, Wisniewski, Stephen R, Manji, Husseini, McMahon, Francis J, Paddock, Silvia

“…Background In a recent study of several antidepressant drugs in hospitalized, non-Hispanic White patients, Binder et al. reported association of markers…”
Get full text

Psychometric and Clinical Evaluation of the Clinician (VQIDS-C 5 ) and Self-Report (VQIDS-SR 5 ) Versions of the Very Quick Inventory of Depressive Symptoms by Rush, A John, Madia, Nancy D, Carmody, Thomas, Trivedi, Madhukar H

“…Evaluate the psychometric properties of the 5-item Very Quick Inventory of Depressive Symptomatology self-report and clinician-rated versions (VQIDS-SR…”
Get full text

Factors That Affect Patient Attrition in Buprenorphine Treatment for Opioid Use Disorder: A Retrospective Real-World Study Using Electronic Health Records by Ker, Sheryl, Hsu, Jennifer, Balani, Anisha, Mukherjee, Sankha Subhra, Rush, A John, Khan, Mehreen, Elchehabi, Sara, Huffhines, Seth, DeMoss, Dustin, Rentería, Miguel E, Sarkar, Joydeep

“…To describe attrition patterns of opioid use disorder (OUD) patients treated with buprenorphine (BUP) and to assess how clinical, sociodemographic, or BUP…”
Get full text

An Evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: A Sequenced Treatment Alternatives to Relieve Depression Trial Report by Rush, A. John, Bernstein, Ira H., Trivedi, Madhukar H., Carmody, Thomas J., Wisniewski, Stephen, Mundt, James C., Shores-Wilson, Kathy, Biggs, Melanie M., Woo, Ada, Nierenberg, Andrew A., Fava, Maurizio

“…Nine DSM-IV-TR criterion symptom domains are evaluated to diagnose major depressive disorder (MDD). The Quick Inventory of Depressive Symptomatology (QIDS)…”
Get full text

Psychometric evaluation and linking of the PHQ-9, QIDS-C, and VQIDS-C in a real-world population with major depressive disorder by Palmer, Emily O C, Ker, Sheryl, Rentería, Miguel E, Carmody, Thomas, Rush, A John

“…Major depressive disorder (MDD) is a leading cause of disability worldwide. An accurate assessment of depressive symptomology is crucial for clinical…”
Get full text

Vagus Nerve Stimulation for Treatment-Resistant Depression: A Randomized, Controlled Acute Phase Trial by Rush, A. John, Marangell, Lauren B., Sackeim, Harold A., George, Mark S., Brannan, Stephen K., Davis, Sonia M., Howland, Robert, Kling, Mitchel A., Rittberg, Barry R., Burke, William J., Rapaport, Mark H., Zajecka, John, Nierenberg, Andrew A., Husain, Mustafa M., Ginsberg, David, Cooke, Robert G.

“…Vagus nerve stimulation (VNS) alters both concentrations of neurotransmitters or their metabolites and functional activity of central nervous system regions…”
Get full text

Randomized, Placebo-Controlled Trial of Mixed Amphetamine Salts for Symptoms of Comorbid ADHD in Pediatric Bipolar Disorder After Mood Stabilization With Divalproex Sodium by Scheffer, Russell E., Kowatch, Robert A., Carmody, Thomas, Rush, A. John

“…OBJECTIVE: The purpose of this study was to determine whether adjunctive use of a psychostimulant (mixed amphetamine salts) was safe and efficacious for…”
Get full text

Setting Measurement-Based Care in Motion: Practical Lessons in the Implementation and Integration of Measurement-Based Care in Psychiatry Clinical Practice by Martin-Cook, Kristin, Palmer, Lucy, Thornton, Larry, Rush, A John, Tamminga, Carol A, Ibrahim, Hicham M

“…Measurement-based care (MBC) involves the systematic use of standardized measurements to inform treatment decisions. MBC can enhance clinical decision-making…”
Get full text